Europe Pet Diseases Treatment Market By Disease Type (Infectious Diseases {Bacterial, Viral, Parasitic}, Non-Infectious Diseases {Chronic Diseases, Allergies and Dermatological Issues, Cancer, Cardiovascular Diseases, Endocrine Disorders}, Genetic Disorders), By Treatment Type (Medication {Prescription medications, Over-the-counter medications}, Surgical Interventions, Preventive Care, Alternative Therapies), By Pet Type (Dogs, Cats, Small Mammals, Others), By End-User (Veterinary Hospitals, Veterinary Clinics, Others), Global Market Size, Segmental analysis, Country Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: May 2025 | Report ID: MI2829 | 218 Pages
Report Coverage:
By Disease Type
- Infectious Diseases
- Bacterial
- Viral
- Parasitic
- Non-Infectious Diseases
- Chronic Diseases
- Allergies and Dermatological Issues
- Cancer
- Cardiovascular Diseases
- Endocrine Disorders
- Genetic Disorders
By Treatment Type
- Medication
- Prescription medications
- Over-the-counter medications
- Surgical Interventions
- Preventive Care
- Alternative Therapies
By Pet Type
- Dogs
- Cats
- Small Mammals
- Others
By End-user
- Veterinary Hospitals
- Veterinary Clinics
- Others
ByRegion
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Switzerland
- Netherlands
- Belgium
- Russia
- Sweden
- Poland
- Portugal
- Greece
- Czech Republic
- Hungary
- Finland
- Norway
- Rest of Europe
List of Companies:
- Virbac
- Dechra Pharmaceuticals
- Vetoquinol
- Chanelle Pharma
- Ceva Santé Animale
- Livisto Group
- Le Vet Pharma
- KRKA
- Richter Pharma
- Biovet
- ECO Animal Health
- Fatro S.p.A.
- Kela nv
- Orion Corporation
- Dopharma
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.